维百奥(北京)生物科技有限公司

400-001-2615
info@vicbio.com
产品名称 AlphaThera | AT7003 | oYo-Link® VcMMAF
目录号 AT7003
别名 AT7003
外观 见COA
分子量 N/A
CAS N/A
溶解度
存储条件 见COA
保存时间 见COA
备注1
备注2
目录号 规格 价格 库存状态  
AT7003 100 μg; Bulk 咨询 咨询


AlphaThera | AT7003 | oYo-Link® VcMMAF


品名:oYo-Link® VcMMAF

货号:AT7003

规格:100 μg; Bulk

品牌:AlphaThera


产品描述

Site-specifically label your antibody with oYo-Link® VcMMAF for cell killing assays to prototype your ADC candidates.

oYo-Link® VcMMAF is an Antibody-Drug Conjugation reagent allowing for site-specific labeling of VcMMAF (Monomethyl Auristatin F) labels to the heavy-chains of oYo-Link®-compatible antibodies with up to two labels per antibody. VcMMAF is an anti-mitotic agent linked via the lysosomally cleavable dipeptide, valine-citrulline (vc). oYo-Link® limits the attachment of the VcMMAF drugs to the heavy chains of the antibody and therefore ensures that the drug label does not interfere with antibody binding. Furthermore, site-specific labeling limits 1-2 VcMMAF drugs to be attached per antibody, providing precise antibody-drug conjugate ratios.

 Applications:Antibody conjugation reagent for Targeted cell death; Targeted cell death for cancer cells; High-throughput screening with cell killing assays.

相关产品